Detailed View

AVAH - Aveanna Healthcare Holdings Inc

Latest filing: 2026-04-04 | Reporting: gaap

Open Yahoo Financials (AVAH)

Back to Dashboard
Market Cap
1,524,286,464
Adj EBIT (TTM)
292,200,000
Enterprise Value
1,335,012,464
Last Price
7
Earnings Yield
21.89%
Return on Capital
69.80%
Capital
418,644,000

1Y Price Chart

Last Price: -
1Y Change: -

Company Summary

Aveanna Healthcare Holdings provides pediatric and adult home health nursing services, including private duty nursing, home health therapy, and hospice care delivered in patients' homes across the United States. The business model is fee-for-service and managed care contracting, with the majority of revenue coming from Medicaid and private insurance reimbursements for medically complex pediatric patients requiring skilled nursing care. Aveanna operates in roughly 33 states and generates approximately $2B in annual revenue, concentrated in the southeastern and midwestern United States. Customers are primarily families of medically fragile children and adults, with payers being state Medicaid programs and commercial insurers rather than the patients themselves.

Past Year Trends

  • Aveanna Healthcare's Q1 2025 revenue grew 14.0% YoY to $559.2 million, accelerating from 8.6% YoY growth in Q4 2024, driven by the preferred payer strategy and Medicaid rate wins across 29 of 30 operating states. (Bullish)
  • Adjusted EBITDA surged 93.1% YoY to $67.4 million in Q1 2025, with full-year 2024 Adjusted EBITDA exceeding $183 million, reflecting successful three-year operational transformation completion and improved payer mix. (Bullish)
  • Aveanna closed a $1.325 billion debt refinancing in September 2025, fully repaying its $415 million second lien term loan facility and extending its first lien maturity to 2032, materially reducing near-term refinancing risk. (Bullish)

Next Year Trends

  • Aveanna is targeting at least 10 additional state Medicaid rate wins in 2026, with estimated 2% to 3% cost-of-living-adjustment-like increases across most states, which directly supports revenue and margin expansion given Medicaid is the dominant payer across its home health footprint. (Bullish)
  • California remains the sole state among Aveanna's 30 operating markets where Medicaid rates did not improve in 2025, representing a concentrated reimbursement headwind in one of the company's larger geographic markets that could weigh on blended rate growth in 2026. (Bearish)
  • The $175.5 million acquisition of Family First, announced in Q1 2025, must be successfully integrated; failure to achieve targeted synergies or unexpected integration costs could pressure the company's highly leveraged balance sheet and its 2026 Adjusted EBITDA guidance trajectory. (Bearish)

Red Flags

[Securities Fraud / Investigation] DOJ issued a Civil Investigation Demand to Comfort Care Hospice LLC, an indirect subsidiary, dated approximately July 2023, alleging improper Medicare claims for ineligible patients and improper remuneration to medical directors and skilled nursing facilities for referrals in violation of federal anti-kickback statutes. — Aveanna Healthcare SEC filings / U.S. Department of Justice, Middle District of Alabama, July 2023

[Securities Fraud / Investigation] Pomerantz Law Firm announced a securities fraud investigation on behalf of AVAH investors concerning whether Aveanna and certain officers/directors engaged in securities fraud or unlawful business practices in connection with the company's public disclosures. — GlobeNewswire / Pomerantz LLP shareholder alert, March 2022

Updated 2026-05-20

endDateformTypefiscalYearRevenueOperatingIncomeLoss
2026-04-0410-Q2027647,915,00069,326,000
2026-01-0310-K (Q4 derived)2026662,480,00071,045,000
2025-09-2710-Q2026621,942,00053,583,000
2025-06-2810-Q2026589,553,00080,034,000
2025-03-2910-Q2026559,224,00051,801,000
2024-12-2810-K (Q4 derived)2024519,872,00045,771,000
2024-09-2810-Q2024509,023,00034,024,000
2024-06-2910-Q2024504,958,00037,126,000

Notice something wrong?

Submit a quick report with a snapshot of the values you are seeing.